Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 241 of the 242 references it cites were found in a registry or an index; none of the 155 sources its claims cite is checked for support yet.
Abstract
This paper discusses the mechanisms of S. aureus drug resistance including: (1) introduction. (2) resistance to beta-lactam antibiotics, with particular emphasis on the mec genes found in the Staphylococcaceae family, the structure and occurrence of SCCmec cassettes, as well as differences in the presence of some virulence genes and its expression in major epidemiological types and clones of HA-MRSA, CA-MRSA, and LA-MRSA strains. Other mechanisms of resistance to beta-lactam antibiotics will also be discussed, such as mutations in the gdpP gene, BORSA or MODSA phenotypes, as well as resistance to ceftobiprole and ceftaroline. (3) Resistance to glycopeptides (VRSA, VISA, hVISA strains, vancomycin tolerance). (4) Resistance to oxazolidinones (mutational and enzymatic resistance to linezolid). (5) Resistance to MLS-B (macrolides, lincosamides, ketolides, and streptogramin B). (6) Aminoglycosides and spectinomicin, including resistance genes, their regulation and localization (plasmids, transposons, class I integrons, SCCmec), and types and spectrum of enzymes that inactivate aminoglycosides. (7). Fluoroquinolones (8) Tetracyclines, including the mechanisms of active protection of the drug target site and active efflux of the drug from the bacterial cell. (9) Mupirocin. (10) Fusidic acid. (11) Daptomycin. (12) Resistance to other antibiotics and chemioterapeutics (e.g., streptogramins A, quinupristin/dalfopristin, chloramphenicol, rifampicin, fosfomycin, trimethoprim) (13) Molecular epidemiology of MRSA.
Overview
CoChat Summary
TL;DR
This review summarizes molecular mechanisms of drug resistance in *Staphylococcus aureus*, covering beta-lactams, glycopeptides, oxazolidinones, MLS-B, aminoglycosides, fluoroquinolones, tetracyclines, mupirocin, fusidic acid, daptomycin, and other agents. It emphasizes SCC*mec*/*mec*-mediated methicillin resistance, VanA-mediated glycopeptide resistance, and mobile genetic elements as drivers of multidrug resistance.
Key findings
- Methicillin resistance is chiefly mediated by PBP2A encoded by *mec* genes within SCC*mec* cassettes; 14 major SCC*mec* types have been described, ranging from 21 to 82 thousand nucleotides, with *mecA*, *mecC*, and other *mec* variants distributed across staphylococci.
- Beta-lactam resistance also involves beta-lactamases (*blaZ*) and rare PBP mutations; a *mecA*-negative CRB strain had ceftobiprole MIC = 128 mg/L, ceftriaxone MIC = 256 mg/L, cefazolin MIC > 256 mg/L, nafcillin MIC = 128 mg/L, ampicillin MIC = 256 mg/L, and cefoxitin MIC = 8 mg/L.
- Glycopeptide resistance via the VanA operon in Tn*1546* confers vancomycin MIC 64–1024 mg/L and teicoplanin MIC 16–512 mg/L; only about a dozen VRSA strains with VanA have been described. In 187 MRSA strains from 41 Spanish hospitals, vancomycin tolerance was 9.6% and teicoplanin tolerance 21.9%.
- Aminoglycoside resistance commonly involves AAC(6′)-Ie/APH(2″)-Ia, the only enzyme known in *S. aureus* to determine gentamicin resistance; gentamicin MICs ranged from 8 mg/L to >1024 mg/L (MIC50 128 mg/L, MIC90 512 mg/L), and tobramycin MICs ranged from 8 to 256 mg/L (MIC50 32 mg/L, MIC90 64 mg/L).
Methods
- Design: narrative review of published literature on molecular resistance mechanisms in *S. aureus*; no systematic review protocol or primary experimental study is described.
- Data or sample: Not stated in the paper; the text cites clinical isolates, strains, plasmids, transposons, integrons, and SCC*mec* elements from prior studies.
- Main analysis: descriptive synthesis organized by antibiotic class and molecular epidemiology, including referenced tables and figures on SCC*mec* types, *mec*/*ccr* complexes, and MRSA clones.
Limitations
- The paper states no limitations section.
- Evident: as a narrative review, it lacks systematic search, inclusion criteria, and formal risk-of-bias assessment.
- Evident: it presents no new primary data and relies on previously published studies; several tables and figures are referenced but not included in the provided text, limiting verification of clone and SCC*mec* details.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 6 Not valid · 95 Not checked · 5 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“In 2006, the first class I integrons, previously described in Gram-negative bacteria, were detected in staphylococci, initially found in coagulase-negative staphylococci and later in S. aureus.”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi L. Zheng M. Xiao Z. Asakura M. Su J. Li L. Yamasaki S. Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China Microbiol. Immunol. 2006 50 463 467 10.1111/j.1348-0421.2006.tb03815.x 16785718 source
- Not checked yetcites [9] Xu Z. Li L. Alam M.J. Zhang L. Yamasaki S. Shi L. First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus Curr. Microbiol. 2008 57 264 268 10.1007/s00284-008-9187-8 18594909 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The cassette genes functioning in these integrons that determine resistance to streptomycin (aadA2, aadA5), chloramphenicol (cmlA1) and trimethoprim (dfrA12, dfr17) have also been described [8,9].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi L. Zheng M. Xiao Z. Asakura M. Su J. Li L. Yamasaki S. Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China Microbiol. Immunol. 2006 50 463 467 10.1111/j.1348-0421.2006.tb03815.x 16785718 source
- Not checked yetcites [9] Xu Z. Li L. Alam M.J. Zhang L. Yamasaki S. Shi L. First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus Curr. Microbiol. 2008 57 264 268 10.1007/s00284-008-9187-8 18594909 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, the mere presence of a pathogenicity factor gene does not always equate to its expression, which is subject to one or more regulatory systems present in the bacterial cell, such as the Agr/Sar system [10]”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [10] Butrico C.E. Cassat J.E. Quorum sensing and toxin production in Staphylococcus aureus osteomyelitis: Pathogenesis and paradox Toxins 2020 12 516 10.3390/toxins12080516 PMC7471978 32806558 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mecA gene has been detected in S. aureus, S. pseudintermedius, Mammallicoccus fleuretti (former name Staphylococcus fleuretti), Mammallicoccus vitulinus (former name Staphylococcus vitulinus), Mammallicoccus sciuri (former name Staphylococcus sciuri) and in many other species of the genus Staphylococcus currently comprising 64 species [21].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.2. PBP2A Synthesis (Methicillin-Resistance)
What the sources say
- Not checked yetcites [21] Taxonomy Browser (Staphylococcus) Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (accessed on 3 February 2022)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Single strains of the so-called BORSA (borderline oxacillin-resistant S. aureus) have been described, in which the synthesized beta-lactamase had an extended spectrum and conditioned an oxacillin MIC of 4–8 mg/L [15].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.1. Synthesis of Beta-Lactamases
What the sources say
- Not checked yetcites [15] Balslev U. Bremmelgaard A. Svejgaard E. Havstreym J. Westh H. An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit Microb. Drug Resist. 2005 11 78 81 10.1089/mdr.2005.11.78 15770100 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 106 claims and to verify the 155 references still open.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In MRSA, PBP2a maintains transpeptidase activity even under β-lactam exposure, enabling cross-linking of pentaglycan bridges between peptidoglycan chains [9,198].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Resistance extends to all β-lactams except ceftobiprole and ceftaroline, which retain activity against PBP2a [9,203].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Constitutive expression occurs in strains with ΔmecR1-mecA deletions [9,202].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“The mecA gene, located on the staphylococcal chromosomal cassette mec (SCCmec), produces PBP2a (also termed PBP2′), a 668-amino-acid protein that replaces the transpeptidase function of native PBPs inhibited by β-lactams [9,195,197].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.3. Resistance to Chloramphenicol
“A mutation in the rpoB gene (A1345G; substitution in RpoB protein D449N) was also described, conditioning the resistance of S. aureus strain to chloramphenicol (MIC-128 mg/L) and intermediate to oxazolidinones [94].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 4. Resistance to Oxazolidinones
“A mutation in the rpoB gene (A1345G; substitution in the RpoB protein D449N) was also described, which determines the resistance of S. aureus strain to linezolid (MIC = 8 mg/L) and tedizolid (MIC = 4 mg/L), chloramphenicol (MIC-128 mg/L), medium sensitivity to quinupristin/dalphopristin (MIC-2 mg/L) [94].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 5. Resistance to Macrolides, Lincosamides, Ketolides and Streptogramins B
“VgbA, VgbB, inactivating streptogramin B lyases”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.1. Resistance to Streptogramins A and Quinupristin-Dalfopristin
“Resistance to streptogramins A in S. aureus may result from the production of enzymes that inactivate streptogramins A such as Vat acetyltransferases encoded by the plasmid genes vatA [179], vatB located in the Tn5406 transposon [180,181], vatC [130], vatD, vatE [130] or Vgb lyases encoded by the vgb(A) and vgb(B) genes [131].”
Citations
Cites
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Kondo, Y., Ito, T., Ma, X. X., Watanabe, S., Kreiswirth, B. N., Etienne, J., & Hiramatsu, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-06 · Cited by 965
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1323-1336.2001 · Cited by 963
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Research works printed but not linked: 1
- Taxonomy Browser (Staphylococcus) Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (accessed on 3 February 2022)
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Mechanism of staphylococcal resistance to clinically relevant antibiotics
Brdová, D., Ruml, T., & Viktorová, J. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101147 · Cited by 135
Bashabsheh, R. H. F., Al-Fawares, O., Natsheh, I. Y., Bdeir, R., Al-Khreshieh, R. O., & Bashabsheh, H. H. F. (2023) · Pathogens and Global Health · doi:10.1080/20477724.2023.2285187 · Cited by 114
Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria
Rajput, P., Nahar, K. S., & Rahman, K. M. (2024) · Antibiotics · doi:10.3390/antibiotics13121197 · Cited by 114
Qiu, M., Zheng, M., Zhang, J., Yang, X., Zhang, Y., Zhang, W., Man, C., Zhao, Q., & Jiang, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117258 · Cited by 78
Hou, Z., Liu, L., Wei, J., & Xu, B. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s412308 · Cited by 67
Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies
Li, J., Cheng, F., Wei, X., Bai, Y., Wang, Q., Li, B., Zhou, Y., Zhai, B., Zhou, X., Wang, W., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14080771 · Cited by 84
A review and meta-analysis of Staphylococcus aureus prevalence in foods
Léguillier, V., Pinamonti, D., Chang, C.-M., Gunjan, Mukherjee, R., Himanshu, Cossettini, A., Manzano, M., Anba‐Mondoloni, J., Malet-Villemagne, J., et al. (2024) · The Microbe · doi:10.1016/j.microb.2024.100131 · Cited by 81
Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus
Lade, H. S., Joo, H., & Kim, J. (2022) · Antibiotics · doi:10.3390/antibiotics11101378 · Cited by 74
Song, M., Tang, Q., Ding, Y., Tan, P., Zhang, Y., Wang, T., Zhou, C., Xu, S., Lyu, M., Bai, Y., et al. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01007-6 · Cited by 75
Zarenezhad, E., Abdulabbas, H. T., Marzi, M., Ghazy, E., Ekrahi, M., Pezeshki, B., Ghasemian, A., & Moawad, A. A. (2022) · Antibiotics · doi:10.3390/antibiotics11091208 · Cited by 71
Recent advances in nanoantibiotics against multidrug-resistant bacteria
Li, M., Liu, Y., Gong, Y., Yan, X., Wang, L., Zheng, W., Ai, H., & Zhao, Y. (2023) · Nanoscale Advances · doi:10.1039/d3na00530e · Cited by 66
Gopikrishnan, M., Haryini, S., & Doss, C. G. P. (2024) · Journal of Basic Microbiology · doi:10.1002/jobm.202300579 · Cited by 72
Tălăpan, D., Sandu, A.-M., & Rafilă, A. (2023) · Antibiotics · doi:10.3390/antibiotics12060974 · Cited by 62
Hernández-Cuellar, E., Tsuchiya, K., Valle‐Rios, R., & Contreras, O. M. (2023) · Diseases · doi:10.3390/diseases11040160 · Cited by 57
Wang, Y., Zhang, P., Wu, J., Chen, S., Jin, Y., Long, J., Duan, G., & Yang, H. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28532-7 · Cited by 56
Romanescu, M., Oprean, C., Lombrea, A., Bădescu, B., Teodor, A., Constantin, G.-D., Andor, M., Folescu, R., Muntean, D., Danciu, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119727 · Cited by 56
Recent advances in the development of antimicrobial peptides against ESKAPE pathogens
Roque‐Borda, C. A., Primo, L. M. D. G., Franzyk, H., Hansen, P. R., & Pavan, F. R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31958 · Cited by 47
Covalent Organic Framework: A Rising Star in Antibacterial Agents
Ding, L., Shi, M., Xu, Y., Yu, E., Zhang, Y., Li, J., Liu, F., Yao, B., Yu, J., & Wu, J. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202411237 · Cited by 43
Advances in the detection of β-lactamase: A review
Qian, Z., Guo, H., Peng, T., Ding, E., Zhao, H., Liu, Q., He, S., & Zhao, G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126159 · Cited by 40
Wu, J., Huang, Y., Ding, X., Kang, L., Wang, X., Li, D., Cheng, W., Liu, G., Xue, J., & Ding, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02002-1 · Cited by 39
Touati, A., Ibrahim, N. A., & Idres, T. (2025) · Pathogens · doi:10.3390/pathogens14040386 · Cited by 44
Vadakkan, K., Sathishkumar, K., Urumbil, S. K., Ponnenkunnathu, S. G., Ngangbam, A. K., & Nongmaithem, B. D. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107465 · Cited by 35
Belete, M. A., Gedefie, A., Alemayehu, E., Debash, H., Mohammed, O., Gebretsadik, D., Ebrahim, H., & Tilahun, M. (2023) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-023-01291-3 · Cited by 37
Morguette, A. E. B., Bartolomeu-Gonçalves, G., Andriani, G. M., Bertoncini, G. E. S., de Castro, I. M., de Almeida Spoladori, L. F., Bertão, A. M. S., Tavares, E. R., Yamauchi, L. M., & Yamada-Ogatta, S. F. (2023) · Plants · doi:10.3390/plants12112147 · Cited by 31
“Recent reviews on the molecular mechanisms of resistance to non-β-lactam agents are available in the literature [30,31].”
BackgroundBuonocore, C., Giugliano, R., Sala, G. D., Esposito, F. P., Tedesco, P., Folliero, V., Galdiero, M., Franci, G., & de Pascale, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020700 · Cited by 31
Mechanisms Operating in the Use of Transition Metal Complexes to Combat Antimicrobial Resistance
Wu, S., Wang, M., Liu, Z., & Fu, C. (2025) · Microorganisms · doi:10.3390/microorganisms13071570 · Cited by 31
Comparative Genomic Analysis of Enterococci across Sectors of the One Health Continuum
Zaidi, S.-E.-Z., Zaheer, R., Poulin‐Laprade, D., Scott, A., Rehman, M. A., Diarra, M. S., Topp, E., Domselaar, G. V., Zovoilis, A., & McAllister, T. A. (2023) · Microorganisms · doi:10.3390/microorganisms11030727 · Cited by 32
El-Sherbiny, G. M., Shehata, M., & Kalaba, M. H. (2025) · Biotechnology Reports · doi:10.1016/j.btre.2025.e00896 · Cited by 35
Biological properties of Staphylococcus virus ΦSA012 for phage therapy
Fujiki, J., Nakamura, T., Nakamura, K., Nishida, K., Amano, Y., Watanabe, Y., Gondaira, S., Usui, M., Shimizu, M., Miyanaga, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25352-6 · Cited by 30
The Pathogenicity Mechanisms of Staphylococcus aureus
Młynarczyk-Bonikowska, B., & Rudnicka, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411803 · Cited by 29
Chew, C. H., Yeo, C. C., Hamzah, A. M. C., Al-Trad, E. I., Jones, S. U., Chua, K. H., & Puah, S. M. (2023) · Diagnostics · doi:10.3390/diagnostics13061050 · Cited by 31
Rahmanian, N., Moulavi, P., Ashrafi, F., Sharifi, A., & Asadi, S. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03615-8 · Cited by 27
Synergistic combination of baicalein and rifampicin against Staphylococcus aureus biofilms
Muniyasamy, R., & Manjubala, I. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1458267 · Cited by 27
Liu, Y., Lu, H., Hu, G., Liu, J., Lian, S., Pang, S., Zhu, G., & Ding, X. (2025) · Microorganisms · doi:10.3390/microorganisms13081928 · Cited by 31
Johansson, M. H. K., Petersen, T. N., Nag, S., Lagermann, T. M. R., Birkedahl, L. E. K., Tafaj, S., Bradbury, S., Collignon, P., Daley, D. A., Dougnon, V. T., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0330304 · Cited by 29
de Oliveira, G. D., da Rocha, W. R. V., Rodrigues, J. F. B., & Alves, H. D. S. (2022) · Pharmaceuticals · doi:10.3390/ph16010055 · Cited by 25
Singh, A., Singh, K., Sharma, A., Kaur, J., Kaur, R., Kaur, J., Kaur, K., Chadha, R., & Bedi, P. M. S. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136557 · Cited by 25
Detection of mecA Genes in Hospital-Acquired MRSA and SOSA Strains Associated with Biofilm Formation
González-Vázquez, R., Córdova-Espinoza, M. G., Escamilla-Gutiérrez, A., Herrera, M. D. R., Gónzalez-Vázquez, R., Esquivel-Campos, A. L., López-Pelcastre, L., Torres-Cubillas, W., Mayorga-Reyes, L., Mendoza‐Pérez, F., et al. (2024) · Pathogens · doi:10.3390/pathogens13030212 · Cited by 25
Secario, M. K., Truong, T. T. V., Chen, C., Lai, J., & Lue, S. J. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105511 · Cited by 26
Fernandez, J. E., Egli, A., Overesch, G., & Perreten, V. (2024) · Nature Communications · doi:10.1038/s41467-024-49644-9 · Cited by 27
Zaghen, F., Sora, V. M., Meroni, G., Laterza, G., Martino, P. A., Soggiù, A., Bonizzi, L., & Zecconi, A. (2023) · Antibiotics · doi:10.3390/antibiotics12071225 · Cited by 26
El-Kattan, N., Ibrahim, M. A., Emam, A. N., Metwally, K., Youssef, F. S., Nassar, N. A., & Mansour, A. S. (2025) · Nanoscale Advances · doi:10.1039/d4na00955j · Cited by 27
New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians
Carcione, D., Intra, J., Andriani, L., Campanile, F., Gona, F., Carletti, S., Mancini, N., Brigante, G., Cattaneo, D., Baldelli, S., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16091304 · Cited by 23
Li, Z., Li, X., Shi, P., Li, P., Fu, Y., Tan, G., Zhou, J., Zeng, J., & Huang, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031429 · Cited by 24
Natural product inspired antibiotics approved for human use – 1943 to 2025
Butler, M. S., & Capon, R. J. (2025) · Natural Product Reports · doi:10.1039/d5np00067j · Cited by 23
Chieffi, D., Fanelli, F., & Fusco, V. (2023) · Frontiers in Food Science and Technology · doi:10.3389/frfst.2023.1165871 · Cited by 22
A look at staphylococci from the one health perspective
Cuny, C., Layer, F., Werner, G., & Witte, W. (2024) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2024.151604 · Cited by 27
Chandra, D. K., Kumar, A., & Mahapatra, C. (2024) · JOM · doi:10.1007/s11837-024-06714-z · Cited by 23
Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens
Sartori, M., Toppo, S., & Lavezzo, E. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1719798 · Cited by 26
Qin, J., Yu, L., Peng, F., Ye, X., Li, G., Sun, C., Cheng, F., Peng, C. Y., & Xie, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1134207 · Cited by 25
Bhattacharya, S., Dutta, A., Khanra, P. K., Gupta, N., Dutta, R., Tzvetkov, N. T., Milella, L., & Ponticelli, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108907 · Cited by 23
Alves, J., Vrieling, M., Ring, N., Yebra, G., Pickering, A. C., Prajsnar, T. K., Renshaw, S. A., & Fitzgerald, J. R. (2024) · mBio · doi:10.1128/mbio.00346-24 · Cited by 20
Changes in oral, skin, and gut microbiota in children with atopic dermatitis: a case-control study
Zhang, X., Huang, X., Zheng, P., Liu, E., Bai, S., Chen, S., Pang, Y., Xiao, X., Yang, H., & Guo, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1442126 · Cited by 21
Ke, S., Kil, H., Roggy, C., Shields, T., Quinn, Z., Quinn, A. P., Small, J. M., Towne, F. D., Brooks, A. E., & Brooks, B. D. (2024) · Antibiotics · doi:10.3390/antibiotics13111046 · Cited by 17
Rothia nasimurium as a Cause of Disease: First Isolation from Farmed Chickens
Zhang, J., Mo, S., Li, H., Yang, R., Liu, X., Xing, X., Hu, Y., & Li, L. (2022) · Veterinary Sciences · doi:10.3390/vetsci9120653 · Cited by 19
Abdullahi, I. N., Latorre-Fernández, J., Reuben, R. C., Trabelsi, I., González‐Azcona, C., Arfaoui, A., Usman, Y., Lozano, C., Zarazaga, M., & Torres, C. (2023) · Microorganisms · doi:10.3390/microorganisms12010066 · Cited by 21
Research and Application of Chitosan Nanoparticles in Orthopedic Infections
Shi, S., Shi, W., Zhou, B., & Qiu, S. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s468848 · Cited by 20
Chong, C. S. C., Lau, Y. Y., Michels, P. A. M., & Lim, C. S. Y. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2473332 · Cited by 23
Guo, J., Pan, Z., Fan, L., Zhong, Y., Pang, R., & Su, Y. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s411658 · Cited by 18
Ali, S. M. A., Khan, J., Shahid, R., Shabbir, S., Ayoob, M. F., & Imran, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134841 · Cited by 18
Mohammed, R., Nader, S. M., Hamza, D. A., & Sabry, M. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-88743-5 · Cited by 18
Touaitia, R., Ibrahim, N. A., Almuqri, E. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Toxins · doi:10.3390/toxins17070323 · Cited by 16
Liang, J., Hu, Y., Fu, M., Li, N., Wang, F., Xiaojun, Y., & Ji, B. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s392908 · Cited by 16
Vo, T., Pontarotti, P., Rolain, J., & Merhej, V. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107154 · Cited by 16
Vázquez-Sánchez, D. A., Grillo, S., Carrera-Salinas, A., González-Díaz, A., Cuervo, G., Grau, I., Camoez, M., Martí, S., Berbel, D., Tubau, F., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10122401 · Cited by 19
Байменов, Б., Bulashev, A. K., Chuzhebaeva, G. D., Aliyeva, G. K., Бейшова, И., Kokanov, S. K., & Raketsky, V. A. (2023) · Veterinary World · doi:10.14202/vetworld.2023.1815-1820 · Cited by 15
Konwar, B., & Kim, K.-S. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165827 · Cited by 15
Li, X., Cai, Y., Xia, Q., Liao, Y., & Qin, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1118793 · Cited by 14
Hou, Z., Xu, B., Liu, L., Yan, R., Zhang, J., Yin, J., Li, P., & Wei, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1273397 · Cited by 14
Jama−Kmiecik, A., Mączyńska, B., Frej−Mądrzak, M., Choroszy−Król, I., Dudek-Wicher, R. K., Piątek, D., Kujawa, K., & Sarowska, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020332 · Cited by 16
Arruda, F., Lima, A. C. V. M. D. R., Wortham, T., Janeiro, A., Rodrigues, T., Baptista, J., Rosa, J. S., & Lima, E. (2024) · Plants · doi:10.3390/plants13131729 · Cited by 19
Antibacterial activities of functional groups on the benzene rings in nucleic acid nanocarriers
Yang, J.-Q., Chen, H. M., Huang, C.-R., Chen, Y., & Chen, Y. (2024) · Materials Today Chemistry · doi:10.1016/j.mtchem.2024.102106 · Cited by 13
A novel α-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms
Rile, G., Zhao, H., Tang, Q., Chandarajoti, K., Bai, H., Wang, X., Zhang, K., Ye, W., Han, X., Wang, C., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01631-24 · Cited by 13
Antimicrobials: An update on new strategies to diversify treatment for bacterial infections
Hibbert, T. M., Krpetić, Ž., Latimer, J., Leighton, H. J., McHugh, R. E., Pottenger, S., Wragg, C., & James, C. E. (2024) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2023.12.002 · Cited by 13
Abbas, M. M., Almasri, M., Abu-Zant, A., Sharef, S., Mahajne, S., & Kananbi, K. (2023) · Quality Assurance and Safety of Crops & Foods · doi:10.15586/qas.v15i4.1380 · Cited by 13
Forecasting the development of antimicrobial resistance of S. aureus
Shemetov, O., Faustova, M. O., Perepelova, T. V., Balia, H. M., Pavlish, І. V., & Loban', G. (2025) · Frontiers in Oral Health · doi:10.3389/froh.2024.1514070 · Cited by 16
Qiu, N., Liu, W., & Zhang, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1582003 · Cited by 12
Zhu, S., Zhang, H., Yang, M., Chen, Y., Hao, Y., Liu, L., & Kang, J. (2025) · Food Control · doi:10.1016/j.foodcont.2025.111556 · Cited by 13
Kazemzadeh, S., Korneeva, O. S., Shabunin, S. V., & Syromyatnikov, M. (2025) · Open Veterinary Journal · doi:10.5455/ovj.2025.v15.i9.5 · Cited by 12
Zhang, J., Tu, J., Chen, Y., & Jin, X. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02921-x · Cited by 12
Chen, S., Zhou, P., Wu, C., Wang, J., Zhou, Y., Zhang, J., Wang, B., Zhao, H., Rao, L., Li, M., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1220683 · Cited by 12
Khairullah, A. R., Kurniawan, S. C., Sudjarwo, S. A., Effendi, M. H., Widodo, A., Moses, I. B., Hasib, A., Zahra, R. L. A., Gelolodo, M. A., Kurniawati, D. A., et al. (2024) · Veterinary World · doi:10.14202/vetworld.2024.216-225 · Cited by 12
Combating multidrug-resistant (MDR) Staphylococcus aureus infection using terpene and its derivative
Salikin, N. H., Keong, L. C., Azemin, W.-A., Philip, N., Yusuf, N., Daud, S. A., & Rashid, S. A. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04190-w · Cited by 11
de Jesus, A. C. S., Ferrari, R. G., Panzenhagen, P., dos Santos, A. M. P., Portes, A. B., & Conte‐Júnior, C. A. (2025) · Antibiotics · doi:10.3390/antibiotics14040364 · Cited by 13
Threat of multidrug resistant bacteria: The role of genomic solutions and a call to action
Mallik, S., Dash, S., Mishra, S., Mohanty, R. B., Sahoo, S., Patra, A., Sahoo, S., Mishra, R., & Mohanty, J. N. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102298 · Cited by 12
Suepaul, S. M., Stegger, M., Boyen, F., Georges, K. C., & Butaye, P. (2023) · Antibiotics · doi:10.3390/antibiotics12081266 · Cited by 11
Roa-Tort, K., Ugalde-Femat, G., Saavedra, Y., Villanueva-Martínez, A., Molina-Alejandre, O., Pérez-Carranza, L. A., de la Rosa, J., Ganem‐Rondero, A., Becerril-Osnaya, A. A., & Rivera-Fernández, J. D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040518 · Cited by 12
Bacterial Contamination of Environmental Surfaces of Veterinary Rehabilitation Clinics
Spratt, H. G., Millis, N., Levine, D. F., Brackett, J., & Millis, D. L. (2024) · Animals · doi:10.3390/ani14131896 · Cited by 11
Soliman, A. M., Ghorab, W. M., Ghorab, M. M., Elkenawy, N. M., El‐Sabbagh, W. A., & Ramadan, L. A. A. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107559 · Cited by 10
Taha, A. B. (2024) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2024.112208 · Cited by 11
Hushyar, S., Doghaheh, H. P., & Arzanlou, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10659-2 · Cited by 10
A systematic review and meta-analysis on antibiotic resistance genes in Ghana
Donkor, E. S., Odoom, A., Osman, A.-H., Darkwah, S. O., & Kotey, F. C. N. (2025) · BMC Medical Genomics · doi:10.1186/s12920-024-02050-y · Cited by 11
Carrasco-Rojas, J., Sandoval, F. I., Schuh, C. M. A. P., Lagos, C. F., Morales, J. O., Arriagada, F., & Ortiz, A. C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060799 · Cited by 10
Hegazy, E. E., Naghy, W. S. E., Shalaby, M. M., Shoeib, S. M., Abdeen, N. S. M., Fouda, M. H., Elshora, O. A., Elnaggar, M. H., Elrefaey, W., Hagag, R. Y., et al. (2025) · Pathogens · doi:10.3390/pathogens14070705 · Cited by 10
Zou, C., Cao, Y., Liu, J., Dong, X., Bi, J., Guo, W., & Fu, S. (2025) · Animals and zoonoses. · doi:10.1016/j.azn.2025.07.004 · Cited by 10
Ibrahim, Y. S., Ramírez‐Coronel, A. A., Sain, D. K., Al‐qaim, Z. H., Jawhar, Z. H., Alabdali, A. Y. M., Ali, S. H. J., Althomali, R. H., Mustafa, Y. F., & Romero‐Parra, R. M. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.108860 · Cited by 10
Trościańczyk, A., Nowakiewicz, A., Kasela, M., Malm, A., Tracz, A. M., Hahaj-Siembida, A., Osińska, M., Gula, S., & Jankowiak, I. (2023) · Antibiotics · doi:10.3390/antibiotics12071137 · Cited by 11
Li, R., Gao, H., Zhang, R., Zhang, R., Wang, X., Wang, X., & Li, R. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113823 · Cited by 10
Chakrawarti, A., Eckstrom, K. M., Laaguiby, P., & Barlow, J. (2024) · Access Microbiology · doi:10.1099/acmi.0.000766.v3 · Cited by 10
Metadata
- Authors
- Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W.
- Affiliations
- Department of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, Koszykowa 82a, 02-008 Warsaw, Poland
- Academy of Face Sculpting, Jana Kazimierza 11B, 01-248 Warsaw, Poland
- Corresponding author
- Marusza, Wojciech
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-22
- Volume
- 23
- Issue
- 15
- Pages
- 8088
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9332259
- OpenAlex
- W4286587477
- Cited by
- 412
- References
- 242
- Citations by year
- 2026: 103 · 2025: 122 · 2024: 114 · 2023: 59 · 2022: 13
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, antibiotic resistance, methicillin-resistant Staphylococcus aureus, beta-lactam resistance, mec gene, glycopeptide resistance, vancomycin resistance, oxazolidinone resistance, linezolid, aminoglycoside resistance, fluoroquinolone resistance, tetracycline resistance, mupirocin resistance, fusidic acid resistance, daptomycin resistance, molecular epidemiology, virulence genes
- MeSH terms
- Aminoglycosides, Anti-Bacterial Agents, Drug Resistance, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.